Structure |
Chemical Name |
CAS |
MF |
 |
Entecavir Impurity 3 |
1391053-94-3 |
C12H15N5O4 |
 |
IBrutinib Impurity C |
|
|
 |
Imatinib impurity 12 |
|
|
 |
Isavuconazole Impurity 20 |
|
|
 |
Isavuconazole Impurity 26 |
|
|
 |
Istradefylline impurity D |
|
|
 |
Leuprorelin EP Impurity F |
1872435-00-1 |
C59H84N16O12 |
 |
Linagliptin Impurity 40 |
|
|
 |
Minocycline N-Hydroxymethyl Impurity |
1075240-33-3 |
C24H29N3O8 |
 |
Mivacurium Chloride Impurity 3 |
740777-60-0 |
C33H46NO9+ |
 |
Mupirocin EP Impurity E |
71087-96-2 |
C26H44O9 |
 |
Nifuratel Impurity 7 |
|
|
 |
Dronedarone Impurity 9 |
|
|
 |
Empagliflozin Impurity 58 |
|
|
 |
Exemestane Impurity 6 |
14895-71-7 |
|
 |
Gadobutrol Impurity 10 |
|
|
 |
Linagliptin Impurity 55 |
|
|
 |
Oseltamivir Impurity 52 |
|
|
 |
Palbociclib Impurity 65 |
|
|
 |
Pimecrolimus Impurity 1 |
|
|
 |
Rosuvastatin Impurity 99 |
|
|
 |
Terbutaline Impurity 18 |
|
|
 |
Ticagrelor Impurity 123 |
|
|
 |
Tofacitinib Impurity 112 |
2179757-75-4 |
C12H19N3O2 |
 |
Trelagliptin Impurity 42 |
|
|
 |
Carbocistein Impurity E |
|
|
 |
Tolvaptan Impurity 35 |
1316312-24-9 |
C10H10ClN |
 |
Erythromycin Impurity F |
|
|
 |
Aztreonam Impurity 1 |
|
|
 |
Trelagliptin Impurity 17 |
865759-02-0 |
C17H20BrFN4O2 |
 |
Dapoxetine Impurity 1 |
2825577-69-1 |
|
 |
Regorafenib Impurity 15 |
|
|
 |
Varenicline Impurity 2 |
|
|
 |
Topiroxostat Impurity 5 |
|
|
 |
Everolimus Impurity 5 |
|
|
 |
Ibrutinib Impurity 3 |
|
|
 |
Canagliflozin Impurity 9 |
|
|
 |
Clopidogrel Impurity 14 |
|
C15H14ClNO2S |
 |
Febuxostat Impurity 53 |
|
|
 |
Cefodizime Impurity C |
|
|
 |
Riociguat IMpurtiy F |
|
|
 |
Nifedipine impurity 10 |
10323-98-5 |
C13H13NO3 |
 |
Cefminox Sodium impurity E |
|
|
 |
Clindamycin Impurity D |
|
|
 |
Fasudil iMpurity C |
|
|
 |
Cefminox Impurity D |
|
|
 |
ソラフェニブN-オキシド |
583840-03-3 |
C21H16ClF3N4O4 |
 |
CHLORHEXIDENE DIACETATE IMPURITY A |
152504-08-0 |
C16H24ClN9 |
 |
Ipragliflozin Impurity 6 |
|
|
 |
Ibrutinib Impurity 27 |
2031255-26-0 |
C26H28N6O3 |
 |
Clopidogrel Impurity 59 |
1122047-98-6 |
C25H26ClNO6S |
 |
Ozagrel Impurity B |
|
|
 |
Ceftriaxone Sodium impurity F |
|
|
 |
(R)-5-(2-fluoro-3-methoxyphenyl)-1-(2-fluoro-6-(trifluoromethyl)benzyl)-6-methyl-3-(2-(2-oxopyrrolidin-1-yl)-2-phenylethyl)pyrimidine-2,4(1H,3H)-dione |
2248628-93-3 |
C32H28F5N3O4 |
 |
Tofacitinib Impurity 35 |
|
|
 |
ethyl 4-(5-methyl-3-phenylisoxazol-4-yl)benzenesulfonate |
1884279-18-8 |
C18H17NO4S |
 |
N-methyl-1-(5-phenyl-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)methanamine fumarate |
928325-82-0 |
C21H21N3O6S |
 |
2,4-ジブロモ-m-クレゾール |
13321-75-0 |
C7H6Br2O |
 |
N-((4-フルオロフェニル)メチル)エタンアミド |
86010-68-6 |
C9H10FNO |
 |
Benzenediazonium, 4-(ethoxycarbonyl)-, chloride |
2028-79-7 |
C9H9ClN2O2 |
 |
2,4-Pteridinediamine,6-(methoxymethyl)- |
40110-13-2 |
C8H10N6O |
 |
Fingolimod EP Impurity D |
780729-32-0 |
C21H37NO2 |
 |
Pentanedioic acid, 2,4-diacetyl-3-(3-nitrophenyl)-, dimethyl ester |
89080-61-5 |
C17H19NO8 |
![2-Thiazoleacetic acid,4-carboxy-2,5-dihydro-5-(4-hydroxybutylidene)-a-[(1R)-1-hydroxyethyl]-, disodium salt, (aS,2R,5Z)- (9CI)](/CAS/20180808/GIF/130609-10-8.gif) |
2-Thiazoleacetic acid,4-carboxy-2,5-dihydro-5-(4-hydroxybutylidene)-a-[(1R)-1-hydroxyethyl]-, disodium salt, (aS,2R,5Z)- (9CI) |
130609-10-8 |
C12H18NNaO6S |
 |
4,4'-Iminodiphenol hydrochloride |
1965310-24-0 |
C12H12ClNO2 |
 |
Cefradine Impurity D |
|
|
 |
Donepezil Impurity |
896134-06-8 |
C17H15NO4 |
 |
1-(2-chloro-5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine |
928325-68-2 |
C17H15ClFN3O2S |
 |
N-methyl-N-(4-nitrophenyl)-2-(piperazin-1-yl)acetamide |
2037385-84-3 |
C13H19ClN4O3 |
 |
N-(3,5-dimethylphenyl)picolinamide |
439591-67-0 |
C14H14N2O |
 |
Neratinib Impurity 6 |
1144516-14-2 |
C26H21ClN6O4 |
 |
Bupivacaine Impurity |
852804-30-9 |
C22H37N2O |
 |
プソイドモン酸D |
85248-93-7 |
C26H42O9 |
 |
Terazosin Impurity |
60548-08-5 |
C19H25N5O4 |
 |
1204612-29-2 |
1204612-29-2 |
C12H18ClNO2 |
 |
(S)-3-(dimethylamino)-1-(thiophen-3-yl)propan-1-ol |
1384080-56-1 |
C9H15NOS |
 |
BDJS-SH 4 |
36588-46-2 |
C12H18N2O2 |
 |
3-Chloro TirofiBan |
2713130-63-1 |
C22H35ClN2O5S |
 |
(Z)-3-(4-クロロベンジリデン)イソベンゾフラン-1(3H)-オン |
105279-16-1 |
C15H9ClO2 |
 |
Blonanserin impurity F |
|
|
 |
Capecitabine Impurity 9 |
|
|
 |
Carfilzomib Impurity E |
|
|
 |
Cefoxitin EP Impurity B |
|
|
 |
Dabigatran Impurity 3 |
|
|
 |
Dexamethasone EP Impurity K |
1809224-82-5 |
C22H26O4 |
 |
FeBuxostat Impurity 41 |
2428631-67-6 |
C19H19N3O3S |
 |
Formoterol Impurity 16 |
|
|
 |
Famotidine EP Impurity I HCl |
|
C8H15N7O2S3 |
 |
替扎尼定EP雜質C |
1147548-83-1 |
C16H14Cl2N10S2 |
 |
nicergoline impurity Q |
|
|
 |
Loratadine Impurity 19 |
79779-58-1 |
C22H24N2O2 |
 |
(Z)-2-chloro-3-hydroxyacrylaldehyde |
50704-42-2 |
C3H3ClO2 |
![(trans)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4''-fluoro-[1,1''-biphenyl]-4-yl)-1-methylpiperidine hydrochloride](/) |
(trans)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4''-fluoro-[1,1''-biphenyl]-4-yl)-1-methylpiperidine hydrochloride |
|
|
 |
Ticagrelor Related Compound 39 |
|
|
 |
Erlotinib Impurity 32 |
|
|
 |
Pramipexole Impurity 36 |
|
|
 |
Teneligliptin Impurity 3 |
|
|
 |
Erlotinib Hydrochloride iMpurity 52 |
|
|
 |
Ornidazole Impurity J |
742020-47-9 |
C7H12N4O3 |
 |
Androstan-17-one,2,3-epoxy-16-(1-pyrrolidinyl) |
159325-45-8 |
C23H35NO2 |